Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1989 3
1990 2
1991 2
1992 5
1993 4
1994 2
1995 2
1996 2
1997 2
1998 2
1999 3
2000 1
2004 1
2005 1
2006 3
2010 1
2011 1
2012 2
2013 5
2014 1
2015 1
2016 1
2017 2
2019 2
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Herzog TJ, Pignata S, Ghamande SA, Rubio MJ, Fujiwara K, Vulsteke C, Armstrong DK, Sehouli J, Coleman RL, Gabra H, Scambia G, Monk BJ, Arranz JA, Ushijima K, Hanna R, Zamagni C, Wenham RM, González-Martín A, Slomovitz B, Jia Y, Ramsay L, Tewari KS, Weil SC, Vergote IB. Herzog TJ, et al. Among authors: vergote ib. Gynecol Oncol. 2023 Mar;170:300-308. doi: 10.1016/j.ygyno.2023.01.003. Epub 2023 Feb 7. Gynecol Oncol. 2023. PMID: 36758420 Clinical Trial.
Incidence and management of edema associated with trebananib (AMG 386).
Monk BJ, Minion L, Lambrechts S, Vergote IB, Devoogdt N, Karlan BY. Monk BJ, et al. Among authors: vergote ib. Gynecol Oncol. 2013 Sep;130(3):636-41. doi: 10.1016/j.ygyno.2013.05.023. Epub 2013 May 23. Gynecol Oncol. 2013. PMID: 23707665 Review. No abstract available.
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.
Raja FA, Counsell N, Colombo N, Pfisterer J, du Bois A, Parmar MK, Vergote IB, Gonzalez-Martin A, Alberts DS, Plante M, Torri V, Ledermann JA. Raja FA, et al. Among authors: vergote ib. Ann Oncol. 2013 Dec;24(12):3028-34. doi: 10.1093/annonc/mdt406. Epub 2013 Nov 4. Ann Oncol. 2013. PMID: 24190964 Free article. Review.
Exenterative surgery.
Vergote IB. Vergote IB. Curr Opin Obstet Gynecol. 1997 Feb;9(1):25-8. Curr Opin Obstet Gynecol. 1997. PMID: 9090478 Review.
Methodology in plasma proteomic pattern experiments.
Van Gorp T, Vergote IB, Pochet NL, Amant F. Van Gorp T, et al. Among authors: vergote ib. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1951-2; author reply 1953. doi: 10.1111/j.1525-1438.2006.00721.x. Int J Gynecol Cancer. 2006. PMID: 17009999 No abstract available.
Surgery for gynecologic malignancies.
Vergote IB. Vergote IB. Curr Opin Oncol. 1993 Sep;5(5):877-84. doi: 10.1097/00001622-199309000-00017. Curr Opin Oncol. 1993. PMID: 8218501 Review.
53 results